本文观察20例初发未治疗的Graves病患者,采用他巴唑单剂短程疗法.于治疗前、缓解停药时及停药半年后测定甲状腺功能、血清Ig及血清酶等,以观察其缓解率及探讨与复发的有关因素.随访观察27月,其结果缓解与复发各占10例,缓解率为50%,与经典的长程分次药物疗法相仿.治疗终止时,甲状腺仍有血管杂音者易复发 In this paper, 20 cases of untreated Graves’ disease were observed and treated with thalidomide single-dose short-course therapy before treatment, relieve withdrawal and withdrawal half a year after the determination of thyroid function, serum Ig and serum enzymes to observe the relief Rate and explore the factors associated with relapse.Follow-up observation of 27 months, the results of mitigation and relapse of 10 cases, the remission rate was 50%, similar to the classic long-term sub-drug therapy at the end of treatment, thyroid gland vascular murmur Easy to relapse